SCHEMBL3557075

SCHEMBL3557075

COc1ccc2c(c1)c(O)c(C)n2S(=O)(=O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 14/20 0.64
POLB P06746 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
PTGDR Q13258 2/20 0.51
PTGDR2 Q9Y5Y4 2/20 0.51
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HTR7 P34969 2/20 0.47
HTR1A P08908 1/20 0.47
DRD2 P14416 1/20 0.47
HTR1D P28221 1/20 0.47
HTR1B P28222 1/20 0.47
HTR1E P28566 1/20 0.47
HTR1F P30939 1/20 0.47
DRD3 P35462 1/20 0.47
KDM4E B2RXH2 1/20 0.46
HTR2A P28223 2/20 0.46
SRC P12931 1/20 0.46
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3558533 0.85 HTR6 (0.54) HTR6POLBL3MBTL1MEN1KMT2A
SCHEMBL3562004 0.84 PTGDR2 (0.51) HTR6PTGDRPTGDR2SRC
SCHEMBL3563869 0.82 HTR6 (0.50) HTR6PTGDRPTGDR2SRC
SCHEMBL3565477 0.82 ACLY (0.57) HTR6PTGDRPTGDR2SRCMAPT
SCHEMBL3558278 0.82 PTGDR2 (0.68) HTR6PTGDRPTGDR2SRC
SCHEMBL3564084 0.81 SRC (0.51) HTR6PTGDRPTGDR2SRC
Oxalic Acid SCHEMBL7448579 0.79 HTR6 (0.71) HTR6PTGDRPTGDR2HTR7HTR1A
SCHEMBL28485336 0.79 HTR6 (0.48) HTR6PTGDRPTGDR2SRC
SCHEMBL5498898 0.78 HTR6 (1.00) HTR6PTGDRPTGDR2HTR7HTR1A
SCHEMBL3560763 0.77 HTR6 (0.72) HTR6PTGDRPTGDR2HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR6 56/4885POLB 3283/4885L3MBTL1 3496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.